Figure 3 : Occurrence of PSA-progress as early indicator of metastasis or recurrence in patients with DNA-diploid and non-diploid cancers
of the prostate after brachytherapy.

Both groups had the same distribution of Gleason-scores [from 223].

Böcking et al.Pathology Discovery  2014 2:7DOI : 10.7243/2052-7896-2-7